Clinical and Developmental Immunology

Volume 2013 (2013), Article ID 981468, 9 pages

http://dx.doi.org/10.1155/2013/981468

Clinical Study

Cysticerci Drive Dendritic Cells to Promote In Vitro and In Vivo Tregs Differentiation

Laura Adalid-Peralta,1,2 Asiel Arce-Sillas,² Gladis Fragoso,³ Graciela Cárdenas,¹ Marcos Rosetti,³ Didier Casanova-Hernández,² Claudia Rangel-Escareño,⁴ Laura Uribe-Figueroa,⁵ Agnes Fleury,1,2,3 and Edda Sciutto2,3

¹Instituto Nacional de Neurología y Neurocirugía, Insurgentes Sur 3877, Col. La Fama, 14269 México, DF, Mexico

²Unidad Periférica para el Estudio de Neuroinflamación del Instituto de Investigaciones Biomédicas de la UNAM en el Instituto Nacional de Neurología Neurocirugía, Insurgentes Sur 3877, Col. La Fama, 14269 México, DF, Mexico

³Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, 04510 México, DF, Mexico

⁴Departamento de Genómica Computacional, Instituto Nacional de Medicina Genómica, INMEGEN. Periférico Sur 4809, Arenal Tepepan, 14610 México, DF, Mexico

⁵Unidad de Genotipificación y Análisis de Expresión Affymetrix, INMEGEN, Periférico Sur 4809, Arenal Tepepan, 14610 México, DF, Mexico

Received 1 March 2013; Accepted 24 April 2013

Academic Editor: Arnon Nagler

Copyright © 2013 Laura Adalid-Peralta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Regulatory T cells (Tregs) play a crucial role in immune homeostasis. Treg induction is a strategy that parasites have evolved to modulate the host’s inflammatory environment, facilitating their establishment and permanence. In human Taenia solium neurocysticercosis (NC), the concurrence of increased peripheral and central Treg levels and their capacity to inhibit T cell activation and proliferation support their role in controlling neuroinflammation. This study is aimed at identifing possible mechanisms of Treg induction in human NC. Monocyte-derived dendritic cells (DC) from healthy human donors, cocultivated with autologous CD4⁺ naïve cells either in the presence or absence of cysticerci, promoted CD25highFoxp3+ Treg differentiation. An increased Treg induction was observed when cysticerci were present. Moreover, an augmentation of suppressive-related molecules (SLAMF1, B7-H1, and CD205) was found in parasite-induced DC differentiation. Increased Tregs and a higher in vivo DC expression of the regulatory molecules SLAMF1 and CD205 in NC patients were also found. SLAMF1 gene was downregulated in NC patients with extraparenchymal cysticerci, exhibiting higher inflammation levels than patients with parenchymal parasites. Our findings suggest that cysticerci may modulate DC to favor a suppressive environment, which may help parasite establishment, minimizing the excessive inflammation, which may lead to tissue damage.

1. Introduction

Natural (thymic) and inducible regulatory T cells (Tregs) play a pivotal role in maintaining the immune system homeostasis. While natural Tregs are produced in the thymus at any time, inducible Tregs acquire a regulatory function in the context of a given infection or a neoplastic process [1]. A variety of inducible Treg subpopulations mediating their immune suppressive effects by different mechanisms have been reported [2–4]. Disregarding their effectiveness in controlling inflammation, it is conceivable that Tregs could promote a more permissive environment for parasite establishment [5, 6]. The increased Treg levels found in many different protozoa and cestode infections are consistent with this possibility [7, 8].

The role of Tregs in neurocysticercosis (NC), a parasitic disease caused by the establishment of Taenia solium metacestode in the central nervous system (CNS), begins to be explored. Increased central and peripheral Treg levels were observed in severe NC patients. These Tregs seem to participate in the control of the inflammatory response, since a negative correlation between the percentage of peripheral Tregs and activated CD8+ and CD4⁺ T cells, along with a depressed T cell proliferative response, was observed [9]. However, the mechanisms underlying Treg induction in NC are still unknown.

Dendritic cells play a prominent role in Treg induction in the beginning of the immune response to pathogens, either by promoting the conversion of naïve T cells to Treg subpopulations or by expanding the population of preexisting Treg cells [10]. Mature DCs direct conventional CD4⁺ cells to become either specific T helper or T regulatory cell subsets, depending on the affinity of their TCR to the antigen, the strength of the costimulatory signals provided by antigen-presenting cells (APCs), and the cytokine milieu. In addition, the absence of inflammation arrests dendritic cells into an immature or semimature state (iDC), which promotes T cell tolerance by conversion of naïve T cells into Tregs [11]. iDCs are characterized by expressing MHC II, by a high phagocytosis capacity, and by low CD80/CD86 expression. iDCs also produce IL-10, but neither IL-12 nor TNFα [10, 12]. Moreover, it has been proposed that preexisting Tregs can educate iDCs to become tolerogenic, promoting Treg generation [10, 13]. Helminths, as well as other pathogens, may modulate the immune tolerance properties of DCs [14–17].

This study was designed to evaluate the capacity of cysticerci to modulate dendritic cells, driving them to Treg induction, both in vitro and in vivo.

2. Materials and Methods

2.1. Parasites

Taenia solium metacestodes were obtained from naturally infected pigs coming from villages of Guerrero, an endemic region in Mexico. Pigs were euthanized according to ethical animal handling regulations in Mexico. Cysticerci were individually harvested from muscle tissue and maintained in RPMI 1640 medium containing 10% fetal calf serum and 1% antibiotics (Invitrogen, NY, USA). Cysticerci of Taenia crassiceps ORF strain were also used in this study to evaluate their potential to induce iDCs, and therefore Tregs. T. crassiceps cysticerci were obtained from infected BALB/cAnN female mice. Parasites were harvested from the peritoneal cavity of stock female mice after 10 weeks of infection.

2.2. Cell Purification and DC Generation in the Presence of Live Cysticerci

Human cells were isolated from buffy coats from blood of healthy donors (Banco de Sangre del Centro Médico Nacional Siglo XXI, México, DF).

A RosetteSep Human CD4⁺ T Cell Enrichment Cocktail kit was used for CD4⁺ T cell purification (StemCell, Vancouver, Canada). Purified CD4⁺ T lymphocytes including >90% of CD3+ CD4⁺ cells were kept frozen at –80°C until used.

Monocyte-derived DCs (MDDCs) were isolated from mononuclear cells from healthy donors using a RosetteSep Human Monocyte Enrichment Cocktail kit (StemCell, Vancouver, Canada). MDDCs were generated as previously reported [18] with only minor modifications. Briefly, monocytes were plated in Petri dishes (P100) at 5 × 10⁵ cells/mL in 10 mL of RPMI 1640 medium (Invitrogen, NY, USA) containing 10% human AB serum (HSAB) and 1% antibiotics, 20 ng/mL IL-4 (eBiosciences CA, USA), and 100 ng/mL granulocyte-macrophage colony-stimulating factor (eBiosciences, San Diego, CA, USA) for 8 days. One half of complete medium, including cytokines, was replaced at day 4.

To evaluate the role of cysticerci during DC differentiation, monocytes were cultured as described above, either with or without vesicular Taenia crassiceps (40 cysts) or Taenia solium (5 cysts) cysticerci per dish. The effect of both cestodes on DC differentiation was tested considering that murine cysticerci may eventually provide a controlled parasite source of purified immune-modulatory components. Dexamethasone at 10-7 M was used as a positive control.

2.3. In Vitro Treg Induction with Cysticercal Antigens

Parasite-induced MDDCs were seeded at 2.5 × 10⁴ cell/mL in 1 mL RPMI 1640 medium (Invitrogen, NY, USA) containing 10% human AB serum and 1% antibiotics (Invitrogen, NY, USA). MDDCs were maintained in culture for 24 h. During this period, dexamethasone at 10-7 M, which maintains a tolerogenic DC phenotype, was used as control [19]. Parasite-induced DCs were pulsed using 3 μg/mL of total antigens from T. crassiceps cysticerci. T. crassiceps antigens were employed considering that T. solium and T. crassiceps cysticerci share in common more than 98% of the expressed antigens [20]. 1.25 × 10⁵ autologous CD4⁺ T lymphocytes were cocultured for 7 days with MDDCs in RPMI 1640 medium (Invitrogen, NY, USA) containing 10% human AB serum and 1% antibiotics (Invitrogen, NY, USA). Then, the phenotype of regulatory T cells was evaluated by flow cytometry as described below. Supernatants of these cultures were used to evaluate cytokine profile.

2.4. Cell Phenotype

The following combination of antibodies was used to characterize the phenotype of MDDCs: (a) MHC-II FITC (mouse IgG2a k), SLAMF1 PE (mouse IgG1 k), CD11c PerCP-eFluor 710 (mouse IgG1 k), and B7/H1 APC (mouse IgG1 k); (b) CD83 FITC, CD80 PE, CD11c PerCP-eFluor 710 (mouse IgG1 k), and CD86 APC (mouse IgG1 k); (c) CD205 FITC (mouse IgG2b k), CD40 PE (mouse IgG1 k), CD11c PerCP-eFluor 710 (mouse IgG1 k), and ILT3 APC (mouse IgG1 k). Inducible regulatory T cell phenotype was assessed using CD127 FITC (mouse IgG1 k), Foxp3 PE (Rat IgG2a k), CD4 PerCp (mouse IgG1 k), and CD25 APC (mouse IgG1 k). Regulatory T cells were intracellularly stained for Foxp3 using the eBiosciences kit (most antibodies used for cell staining were purchased from eBiosciences, CA, USA). All antibodies were titrated for optimal detection of positive populations prior to its use, considering the manufacturer’s recommended concentrations.

For cytometry analyses, cells were first gated according to lymphocyte forward and side light-scattering properties. Treg numbers were defined as the fraction of Foxp3+ cells among CD4⁺ CD25high cells.

2.5. Cytokines

Cytokine levels in supernatants were measured using the cytometric bead array Cytokine Kit II (BD Biosciences Pharmingen, CA, USA), according to the manufacturer’s instructions, in an FACSCalibur cytometer. Data were analyzed with the BD Cytometric Bead Array software (BD Biosciences Pharmingen, CA, USA). Flow cytometer was calibrated using BD FACSComp (BD Biosciences Pharmingen, CA, USA) and BD CaliBRITE beads (BD Biosciences Pharmingen, CA, USA). Assay sensitivities were set as follows: IL-2 (2.6 pg/mL), IL-6 (3.0 pg/mL), IL-10 (2.8 pg/mL), TNF-α (2.8 pg/mL), and IFN-γ (7.1 pg/mL). TGF-β were measured using the human/mouse TGF-beta 1 ELISA Ready-SET-Go (eBiosciences, CA, USA). ELISA was performed according to the manufacturer’s instructions; detection limit was 60 pg/mL. All samples were run in duplicate.

2.6. DC and Treg Phenotype in NC Patients

Blood samples from 13 patients who attended at the Instituto Nacional de Neurología y Neurocirugía and Centro Médico Nacional Siglo XXI in Mexico City with confirmed NC diagnosis were included in this study. All samples were taken before any treatment was administered. Eight male (age mean 56.25 ± 3.8 years) and five female (age mean 37 ± 1.6 years) patients were included in this study.

In all cases, NC was diagnosed based on clinical manifestations (seizures, focal deficit, and intracranial hypertension) and radiological studies such as MRI and computed tomography (CT).

Vesicular parasites were observed in most cases (12/13 patients). A solitary cysticercus was seen in 9 patients, and multiple cysticerci in 2 patients; the rest of the patients had calcified and colloidal forms. In seven patients, parasite was located at the subarachnoid space of the base (SAB), while the rest of the patients showed parasites at the cerebral parenchyma (P). Patients with SAB cysticerci exhibited inflammatory traits in cerebral spinal fluid (glucose 30.7 ± 28 mg/dL, proteins 421 ± 407 mg/dL, and 70.7 ± 96.9 cell/mm³). In contrast, patients with parenchymal cysticerci showed no inflammation signs. Blood samples from 5 healthy subjects were included as controls.

2.7. Microarrays

DNA microarrays were used to compare the gene expression profile of mononuclear peripheral cells (PBMCs) from a cohort of 8 NC patients, 40 ± 14 years old. PBMC from all patients were obtained 8 days after cysticidal treatment with albendazole, 30 mg per kg, and concomitant corticosteroid administration. These 8 (4 females and 4 males) patients showed cysticerci in different locations. Cysticerci were established in the subarachnoid basal space or in the ventricles (SAB/IV) in 5 patients and were established in the cerebral parenchyma (P) in 3 patients. When required for patients’ followup, CSF was obtained by lumbar puncture at the National Institute of Neurology and Neurosurgery of Mexico City. A mean of 74 cell/mm³ (range 1–261) was found in SAB/IV-NC patients, and a mean of 6.6 cell/mm³ (range 0–18) cells was found in P-NC patients. PBMCs were isolated and then cultured by 72 h with T. solium cysticercal antigens, obtained as previously described [21].

Recovered cells were placed in TRIzol (Gibco, NY, USA) for RNA purification using the RNeasy mini kit (QIAGEN, TX, USA) following the manufacturer’s instructions. The amount of obtained RNA was estimated in an Agilent 2100 Bioanalyzer (Agilent Technologies, Waldbronn, Deutschland). Comparisons were done with respect to parasite location (SAB/IV-NC versus P-NC) using the R-language platform, under the terms of the Free Software Foundations GNU General License (see http://cran.r-project.org/). Data were standardized and normalized. All genes were analyzed using the Reactome software (see http://www.reactome.org/) to find a possible biological pathway involved.

2.8. Ethical Considerations

The present study fulfilled all regulations for research with human subjects as required by the Mexican law and international regulations. It also complied with all ethical aspects considered in the General Rules of Health for Clinical Investigation. Ethics Committee at Instituto Nacional de Neurología y Neurocirugía, México approved the protocol. Written informed consent was obtained from all participants. Patients were informed that samples obtained would be used for this work.

2.9. Statistical Analysis

Data were processed in InStat (GraphPad Software Inc., CA, USA). Variables were described using mean ± SD. Differences between groups were calculated with Students’ -test. values less than 0.05 were considered significant.

3. Results

3.1. Effect of Cysticerci on Dendritic Cell Phenotype

The semimature DC phenotype is associated with tolerance and Treg induction [12]. To evaluate the effect of cysticerci on dendritic cell differentiation, the phenotype of DC generated from CD14+ monocytes either in the presence or absence of vesicular cysticerci after 8-day culture was studied. Dexamethasone (10-7 M) was employed as a positive control (Figure 1). The expression of CD83+, as well as the costimulatory (CD80, CD86, CD40, HLA-DR) and regulatory molecules (SLAMF1, B7-H1, CD205, and ILT3) on CD11c+, was measured. As shown in Figure 1, a higher expression of SLAMF1, B7-H1, and CD205 was observed in cells differentiated in the presence of cysticerci. The expression of HLA-DR, CD80, CD83, CD86, CD40, and ILT3 molecules did not differ between control and parasite-driven differentiated DC cells. On the other hand, CD80, CD40, and SLAMF1 were diminished in dexamethasone-treated cells with respect to control (Figure 1). HLA-DR and ILT3 expression did not differ from control at any tested condition (data not shown). Altogether, these results indicate that parasite promotes the expression of molecules related to a DC tolerogenic phenotype.

Figure 1: Parasite effect on DC differentiation and activation. Monocytes were differentiated to DC in presence of IL-4 and GM-CSF, plus medium or dexamethasone or Taenia crassiceps cysticerci. On day 8, the DC phenotype was studied. Representative data of three independent experiments are shown. Expression of CD80, CD83, CD86, CD40, SLAMF1, B7-H1, and CD205 gated on CD11c+ cells was analyzed by FACS. The isotype controls are shown in white histograms.

3.2. Taenia Solium and T. crassiceps Cysticerci Promote In Vitro Regulatory T Cells Differentiation

We investigated whether differentiation in vitro in the presence of live cysticerci stimulated the differentiation to CD4⁺ CD25high Foxp3+ Tregs. Human DCs, either differentiated in the presence or absence of cysticerci, were pulsed or not with cysticercal proteins and used to stimulate autologous CD4⁺ T lymphocytes. Seven days later, the expression of CD25high and Foxp3 within CD4⁺ T lymphocytes was measured. As a positive control of Treg induction, differentiated DCs were treated with dexamethasone (10-7 M). As shown in Figure 2, cocultivation with cysticerci significantly increased the percentage of CD4⁺ lymphocytes coexpressing the CD25high and Foxp3 fraction with respect to non-stimulated DC, from 115 ± 13.7 to 214.6 ± 76.3 when cocultured with T. crassiceps () and to 321.2 ± 115 () when cocultured with T. solium cysticerci. When DCs were pulsed with parasite antigens, Treg cells were also significantly increased, from 101.2 ± 33 to 273 ± 86.5 () with T. crassiceps-differentiated DC cells, and to 339.3 ± 38.6 () with T. solium-differentiated DC cells (Figure 2).

(a)

(b)

Figure 2: In vitro differentiation of dendritic cells in the presence of Taenia solium or T. crassiceps cysticerci promotes Treg induction. (a) Increased percentage in Treg cell induction. Percentage was calculated as follows: (percentage of Tregs induced/percentage of basal Tregs) × 100. Different letters indicate significant differences between groups at . (b) Representative histograms showing Foxp3 induction within CD4⁺ CD25high cells. Data are representative of three independent experiments.

3.3. Cytokine Profile

The levels of induced cytokines were measured in supernatants from in vitro DC differentiation after 8 days of culture and from in vitro Treg induction after 7 days of culture. During DC differentiation, only IL-10 was significantly increased when cells were differentiated in presence of dexamethasone (Table 1). No difference was observed in the other tested conditions.

Table 1: Levels of cytokines in supernatants from in vitro DC differentiation and in vitro regulatory T cell induction.

IFN-
TNF-
IL-10
IL-6
IL-2
TGF-

DC nonstimulated
0.39 ± 0.88
3.98 ± 3.82
3.17 ± 1.79
>5000
0.34 ± 0.77
406.50 ± 191.69

Control medium 10% HSAB
3.55 ± 0.51
5.78 ± 1.79
5.12 ± 1.50
>5000
1.59 ± 1.41
ND

  differentiation in the presence of

    Dexamethasone
0
3.12 ± 0.47
30.84 ± 5.82a
>5000
0
545.17 ± 289.37

    Taenia crassiceps
0.78 ± 1.75
2.98 ± 1.75
3.77 ± 1.76
>5000
0.72 ± 0.98
341.50 ± 238.19

    Taenia solium
0
4.58 ± 4.44
7.31 ± 4.88
>5000
0
436.00 ± 243.95

Treg induction from naïve CD4⁺  cells

    DC nonstimulated, nonpulsed (Ag⁻)
0.76 ± 1.31
1.21 ± 1.07
0.99 ± 0.93
2.58 ± 0.70
0.45 ± 0.78
124.60 ± 5.35

    DC nonstimulated pulsed (Ag⁺)
0.78 ± 1.75
2.06 ± 0.88
1.22 ± 1.12
2.78 ± 0.60
0.43 ± 0.95
93.07 ± 16.98

    Dexamethasone nonpulsed (Ag⁻)
0.63 ± 1.26
1.68 ± 0.34
1.01 ± 1.18
2.97 ± 2.02
0.39 ± 0.78
95.49 ± 19.66

    Dexamethasone pulsed (Ag⁺)
1.00 ± 1.74
2.49 ± 0.36
2.32 ± 1.36
2.78 ± 1.10
1.38 ± 1.27
98.63 ± 26.39

    T. crassiceps nonpulsed (Ag⁻)
1.23 ± 2.13
2.09 ± 0.79
1.02 ± 1.76
8.15 ± 1.26
1.31 ± 1.21
99.22 ± 31.64

    T. crassiceps pulsed (Ag⁺)
1.26 ± 1.81
2.18 ± 0.38
1.44 ± 0.81
29.34 ± 46.75
0.43 ± 0.95
119.80 ± 42.56

    T. solium nonpulsed (Ag⁻)
4.50 ± 2.61
2.35 ± 0.68
1.48 ± 2.10
56.99 ± 5.21
12.14 ± 11.79
111.00 ± 3.54

    T. solium pulsed (Ag⁺)
1.73 ± 2.45
2.28 ± 0.68
1.95 ± 0.09
11.68 ± 6.02
6.61 ± 6.16
78.50 ± 21.21

    Control T cell
1.54 ± 1.41
1.90 ± 0.48
1.77 ± 0.99
2.01 ± 0.45
0.88 ± 1.20
101.00 ± 16.58

Significantly different () compared to nonstimulated DC.   AB sera from healthy donors were used in DC differentiation experiments. Levels of cytokines in the control medium supplemented with 10% HSAB are shown.

3.4. Dendritic Cells and Regulatory T Cells in NC Patients

The in vivo effect of parasite products on the phenotype of peripheral DC from NC patients was studied. The percentage of DC and the expression of regulatory (SLAMF1, CD205, and ILT3) and costimulatory molecules (HLA-DR, CD86, and CD40) in CD11c cells in 13 NC patients and 5 healthy subjects was measured. As Table 2 shows, SLAMF1, and CD205 are significantly increased in DC from NC patients from 3.8 to 9.7 and from 4.3 to 21.5, respectively (). Moreover, peripheral Tregs are also increased in NC patients from 4.35 to 14.22.

Table 2: Phenotype of peripheral dendritic and regulatory T cells in NC patients and healthy subjects.

Phenotype
NC patients
Healthy subjects
P

Dendritic cells

 SLAM⁺CD11C⁺
9.65 ± 5.66
3.80 ± 1.88
0.045

 CD205⁺CD11C⁺
21.55 ± 13.64
4.27 ± 3.12
0.014

 ILT3⁺CD11C⁺
35.01 ± 27.61
31.48 ± 28.70
0.813

 HLA-DR⁺CD11C⁺
71.47 ± 19.87
69.05 ± 12.96
0.805

 CD86⁺CD11C⁺
39.70 ± 25.87
54.21 ±12.45
0.250

 CD40⁺CD11C⁺
7.92 ± 7.98
2.81 ± 1.49
0.182

T cells

 CD4⁺CD25 High        

 FoxP3⁺CD127−/low
14.22 ± 9.08
4.35 ± 4.26
0.0194

T lymphocytes
30.85 ± 11.49
43.59 ± 5.60
0.07

3.5. SLAMF1 Is Downregulated in PBMC from Patients with SAB/IV Parasites

As Table 3 shows, only four immune-related genes of the 32,322 included in the array were found downregulated in severe SAB/IV-NC patients with respect to P-NC patients. Among them figures the SLAMF1 gene, whose expressed protein was also found in dendritic cells from non-treated NC patients (Table 2). The other downregulated genes found in these patients were MTOR, NFKB2, and IL12RB2 (Table 3). In these severe SAB/IV-NC patients, TGB2 and IL24 genes were found to be up-regulated.

Table 3: Genes differentially expressed in NC patients with respect to the parasite location after 8 days of treatment.

NC caused by cysticerci localized in the subarachnoid base or intraventricular versus parenchymal

Genes
Log

Downregulated
MTOR
−0.69
0.95

NFKB2
−0.93
0.78

SLAMF1
−1.05
2.18

IL12RB2
−0.81
1.19

Upregulated
IL24
0.82
0.96

TGFB2
1.06
2.13

The log fold change (Log FC) describes how much a quantity changes from an initial to a final value in a determinate gene. B value represents the possibility that the gene is differentially expressed.

4. Discussion

Tregs play a pivotal role in modulating the host environment, so parasites may find more appropriate conditions for their establishment and development [7]. It is also possible that Tregs may favor the parasite persistence even when a specific treatment is used to promote the destruction of the parasite [22]. During Taenia solium infection, an increase in the levels of regulatory T cells in blood and CSF in NC patients has been observed, probably promoted by the parasite for controlling the central inflammatory environment and thus favoring its survival [9]. Increased Tregs in NC patients may result from expanded natural Tregs or may be induced by the parasite. The latter possibility was explored herein. On the other hand, DCs may drive T cell differentiation to regulatory or effector cells, depending on their activation status. In this study, in vivo and in vitro lines of evidence point to the effect of cysticercal components on the activation of dendritic cells and their impact on promoting T cell differentiation to CD25high Foxp3+ CD4 T cells. Indeed, co-cultivation of dendritic cells with either T. solium or T. crassiceps cysticerci promotes a status that favors the differentiation of peripheral T cells to CD4⁺ Tregs. Comparable results were found when peripheral cells from non-treated NC patients were studied.

The similar effects induced by the presence both of T. solium or T. crassiceps cysticerci merit some comments. It is well known that both cestodes share multiple antigens [23], a fact that has been exploited to use the murine cysticercal antigens for diagnosis [24, 25].

Parasite-differentiated dendritic cells show no difference with respect to control in the maturation marker (CD83), neither in the costimulatory molecules HLA-DR, CD80, CD86, or CD40; these findings are compatible with an immature dendritic phenotype. In contrast, an overexpression of SLAMF1, B7-H1, and CD205 was observed. The latter two molecules are related to a tolerogenic DC phenotype, as reported in many studies [12, 26]. It is important to note that the expression of SLAMF1, B7-H1, and CD205 was found accompanied by Treg induction in this study, as well. However, their participation in Treg induction remains to be elucidated. This may be particularly relevant since no increase in the two main regulatory cytokines, IL10 and TGFβ, was observed in the supernatants recovered during in vitro Treg induction (Table 1). An increased expression of SLAMF1 and CD205 in dendritic cells and in CD25high Foxp3+ CD4 T cells was observed in NC patients. Both in vitro and in vivo findings reinforce the relevance of SLAMF1 and CD205 dendritic cells, defining their critical role in T cell immunity regulation [27, 28].

It is also worth noticing the downexpression of SLAMF1 in the group of 8 SAB/IV-NC patients with respect to those patients harboring cysticerci in the parenchyma. This apparent discordance with the in vitro results from nontreated NC patients can be traced to differences promoted by in vivo or in vitro conditions, which may differentially modulate the expression of the SLAM-associated protein (SAP) in lymphocytes. Indeed, the expression of this adaptor SAP protein promotes the inflammatory response, while its absence promotes a regulatory environment [28]. SLAM-family receptors presenting cells ligands carry out important immunomodulatory functions: by one side, they regulate lymphocyte interactions and adhesion [28, 29] as well as a tolerogenic immune profile [11, 12]. Although there is no previous information about the functions of SLAM receptors during NC, the results shown in this study point to their possible participation in modulating the inflammatory response promoted by cysticidal and/or corticosteroid treatments. Changes found in MTOR, IL12RB2, NFKB2, and TGF-β genes match with an immunoregulatory environment. MTOR [30], IL12RB2 [31], and NFKB2 [32, 33] genes, coding for proteins that promote an inflammatory environment, are found downregulated, whilst TGF-β, which promotes a regulatory immune response [7], was up-regulated.

5. Conclusions

Overall, the results shown in this study reinforce our previous findings on the relevance of Tregs in controlling the extent of the inflammatory response in NC patients, and added in vivo and in vitro lines of evidence that cysticerci may drive a particular dendritic cell phenotype that induces regulatory T cells, even though the mechanisms that underlined this phenomenon remain to be elucidated. Additionally, while the clinical relevance of the promotion of this regulatory environment needs to be evaluated, it is feasible to propose that it could favor parasite survival.

Acknowledgments

This study was supported by CONACYT (CB-2008-01 100708, CB-2011-01 167278 and 86527) and by DGAPA IN213911, Mexico. Juan Francisco Rodríguez proofread the English version of this paper. The authors thank to Marisela Hernández for her technical assistance and Carlos Castellanos Barba for his technical assistance in flow cytometry.

References

J. F. Heiber and T. L. Geiger, “Context and location dependence of adaptive Foxp3⁺ regulatory T cell formation during immunopathological conditions,” Cellular Immunology, vol. 279, no. 1, pp. 60–65, 2012.

I. Apostolou, A. Sarukhan, L. Klein, and H. von Boehmer, “Origin of regulatory T cells with known specificity for antigen,” Nature Immunology, vol. 3, no. 8, pp. 756–763, 2002.

A. N. Akbar, L. S. Taams, M. Salmon, and M. Vukmanovic-Stejic, “The peripheral generation of CD4⁺ CD25⁺ regulatory T cells,” Immunology, vol. 109, no. 3, pp. 319–325, 2003.

L. W. Collison, V. Chaturvedi, A. L. Henderson et al., “IL-35-mediated induction of a potent regulatory T cell population,” Nature Immunology, vol. 11, no. 12, pp. 1093–1101, 2010.

R. M. Maizels, A. Balic, N. Gomez-Escobar, M. Nair, M. D. Taylor, and J. E. Allen, “Helminth parasites—masters of regulation,” Immunological Reviews, vol. 201, pp. 89–116, 2004.

R. M. Maizels and M. Yazdanbakhsh, “Immune regulation by helminth parasites: cellular and molecular mechanisms,” Nature Reviews Immunology, vol. 3, no. 9, pp. 733–744, 2003.

L. Adalid-Peralta, G. Fragoso, A. Fleury, and E. Sciutto, “Mechanisms underlying the induction of regulatory T cells and its relevance in the adaptive immune response in parasitic infections,” International Journal of Biological Sciences, vol. 7, no. 9, pp. 1412–1426, 2011.

R. M. Maizels, E. J. Pearce, D. Artis, M. Yazdanbakhsh, and T. A. Wynn, “Regulation of pathogenesis and immunity in helminth infections,” Journal of Experimental Medicine, vol. 206, no. 10, pp. 2059–2066, 2009.

L. Adalid-Peralta, A. Fleury, T. M. Garciá-Ibarra et al., “Human neurocysticercosis: in vivo expansion of peripheral regulatory T cells and their recruitment in the central nervous system,” Journal of Parasitology, vol. 98, no. 1, pp. 142–148, 2012.

R. A. Maldonado and U. H. von Andrian, “How tolerogenic dendritic cells induce regulatory T cells,” Advances in Immunology, vol. 108, no. C, pp. 111–165, 2010.

H. H. Smits, E. C. De Jong, E. A. Wierenga, and M. L. Kapsenberg, “Different faces of regulatory DCs in homeostasis and immunity,” Trends in Immunology, vol. 26, no. 3, pp. 123–129, 2005.

S. Rutella, S. Danese, and G. Leone, “Tolerogenic dendritic cells: cytokine modulation comes of age,” Blood, vol. 108, no. 5, pp. 1435–1440, 2006.

M. Kornete and C. A. Piccirillo, “Functional crosstalk between dendritic cells and Foxp3⁺ regulatory T cells in the maintenance of immune tolerance,” Frontiers in Immunology, vol. 3, article 165, 2012.

P. Mukherjee and V. S. Chauhan, “Plasmodium falciparum-free merozoites and infected RBCs distinctly affect soluble CD40 ligand-mediated maturation of immature monocyte-derived dendritic cells,” Journal of Leukocyte Biology, vol. 84, no. 1, pp. 244–254, 2008.

M. Segura, Z. Su, C. Piccirillo, and M. M. Stevenson, “Impairment of dendritic cell function by excretory-secretory products: a potential mechanism for nematode-induced immunosuppression,” European Journal of Immunology, vol. 37, no. 7, pp. 1887–1904, 2007.

D. Van der Kleij, E. Latz, J. F. H. M. Brouwers et al., “A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization,” Journal of Biological Chemistry, vol. 277, no. 50, pp. 48122–48129, 2002.

C. C. Keller, O. Yamo, C. Ouma et al., “Acquisition of hemozoin by monocytes down-regulates interleukin-12 p40 (IL-12p40) transcripts and circulating IL-12p70 through an IL-10-dependent mechanism: in vivo and in vitro findings in severe malarial anemia,” Infection and Immunity, vol. 74, no. 9, pp. 5249–5260, 2006.

N. Cohen, E. Mouly, H. Hamdi et al., “GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response,” Blood, vol. 107, no. 5, pp. 2037–2044, 2006.

G. B. Ferreira, F. S. Kleijwegt, E. Waelkens et al., “Differential protein pathways in 1, 25-dihydroxyvitamin D₃ and dexamethasone modulated tolerogenic human dendritic cells,” Journal of Proteome Research, vol. 11, no. 2, pp. 941–971, 2012.

C. Larralde, R. M. Montoya, E. Sciutto, M. L. Diaz, T. Govezensky, and E. Coltorti, “Deciphering western blots of tapeworm antigens (Taenia solium, Echinococcus granulosus, and Taenia crassiceps) reacting with sera from neurocysticercosis and hydatid disease patients,” American Journal of Tropical Medicine and Hygiene, vol. 40, no. 3, pp. 282–290, 1989.

A. Chavarria, A. Fleury, R. J. Bobes, J. Morales, G. Fragoso, and E. Sciutto, “A depressed peripheral cellular immune response is related to symptomatic neurocysticercosis,” Microbes and Infection, vol. 8, no. 4, pp. 1082–1089, 2006.

A. Verma, K. N. Prasad, S. S. Cheekatla, K. K. Nyati, V. K. Paliwal, and R. K. Gupta, “Immune response in symptomatic and asymptomatic neurocysticercosis,” Medical Microbiology and Immunology, vol. 200, no. 4, pp. 255–261, 2011.

E. Sciutto, G. Fragoso, L. Trueba et al., “Cysticercosis vaccine: cross protecting immunity with T. solium antigens against experimental murine T. crassiceps cysticercosis,” Parasite Immunology, vol. 12, no. 6, pp. 687–696, 1990.

G. C. Arruda, A. D. T. Da Silva, E. M. A. B. Quagliato, M. A. Maretti, and C. L. Rossi, “Evaluation of Taenia solium and Taenia crassiceps cysticercal antigens for the serodiagnosis of neurocysticercosis,” Tropical Medicine and International Health, vol. 10, no. 10, pp. 1005–1012, 2005.

R. H. S. Peralta, A. J. Vaz, A. Pardini et al., “Evaluation of an antigen from Taenia crassiceps cysticercus for the serodiagnosis of neurocysticercosis,” Acta Tropica, vol. 83, no. 2, pp. 159–168, 2002.

H. Hamdi, V. Godot, M. C. Maillot et al., “Induction of antigen-specific regulatory T lymphocytes by human dendritic cells expressing the glucocorticoid-induced leucine zipper,” Blood, vol. 110, no. 1, pp. 211–219, 2007.

T. Fukaya, R. Murakami, H. Takagi et al., “Conditional ablation of CD205⁺ conventional dendritic cells impacts the regulation of T-cell immunity and homeostasis in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 28, pp. 11288–11293, 2012.

P. L. Schwartzberg, K. L. Mueller, H. Qi, and J. L. Cannons, “SLAM receptors and SAP influence lymphocyte interactions, development and function,” Nature Reviews Immunology, vol. 9, no. 1, pp. 39–46, 2009.

A. Veillette, Z. Dong, and S. Latour, “Consequence of the SLAM-SAP signaling pathway in innate-like and conventional lymphocytes,” Immunity, vol. 27, no. 5, pp. 698–710, 2007.

J. H. Lee, J. P. Lydon, and C. H. Kim, “Progesterone suppresses the mTOR pathway and promotes generation of induced regulatory T cells with increased stability,” European Journal of Immunology, vol. 42, no. 10, pp. 2683–2696, 2012.

F. Sinigaglia, D. D'Ambrosio, P. Panina-Bordignon, and L. Rogge, “Regulation of the IL-12/IL-12R axis: a critical step in T-helper cell differentiation and effector function,” Immunological Reviews, vol. 170, pp. 65–72, 1999.

E. F. Lind, C. L. Ahonen, A. Wasiuk et al., “Dendritic cells require the NF-κB2 pathway for cross-presentation of soluble antigens,” Journal of Immunology, vol. 181, no. 1, pp. 354–363, 2008.

D. Artis, S. Shapira, N. Mason et al., “Differential requirement for NF-κB family members in control of helminth infection and intestinal inflammation,” Journal of Immunology, vol. 169, no. 8, pp. 4481–4487, 2002.